Table 3. Association with overall survival and clinicopathological characteristics in patients from the TCGA database using Cox regression.
Clinicopathological variables | Hazard ratio (95% CI) | p-value |
---|---|---|
(A) | ||
Age (continuous) | 1.02 (1.00–1.04) | 0.012 |
Gender (male vs. female) | 1.01 (0.67–1.54) | 0.951 |
RUNX1 expression (high vs. low) | 1.60 (1.31–1.97) | 0.000 |
Grade | 2.24 (1.68–2.99) | 0.000 |
Stage | 1.86 (1.54–2.25) | 0.000 |
Distant metastasis (positive vs. negative)a | 4.07 (2.63–6.30) | 0.000 |
Tissue infiltration (positive vs. negative)b | 3.31 (2.17–5.06) | 0.000 |
Lymph node metastasis (positive vs. negative)c | 2.93 (1.52–5.67) | 0.001 |
(B) | ||
Age (continuous) | 1.03 (1.01–1.05) | 0.002 |
RUNX1 expression (high vs. low) | 1.50 (1.20–1.87) | 0.000 |
Distant metastasis (positive vs. negative) | 2.42 (1.14–5.16) | 0.022 |
Notes.
Positive indicates distant metastasis and negative indicates no distant metastasis.
Positive indicates tissue infiltration and negative indicates no tissue infiltration.
Positive indicates lymph node metastasis and negative indicates no lymph node metastasis.